For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260206:nRSF9741Ra&default-theme=true
RNS Number : 9741R Kosmos Energy Limited 06 February 2026
Kosmos Energy Ltd (the "Company")
PDMR Shareholding
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE
EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES
06 February 2026
The following Persons Discharging Managerial Responsibilities ("PDMRs") have
had changes in their shareholdings of Common Stock in the Company:
PDMR Date of transaction No. of shares vested No. of shares granted No. of shares sold or withheld
Josh R. Marion 31 January 2026 0 58,080 0
Josh R. Marion 3 February 2026 7661 0 19,656
Josh R. Marion 4 February 2026 0 0 3,284
Ronald W. Glass 31 January 2026 0 55,000 0
Ronald W. Glass 3 February 2026 7,732 0 19,285
Ronald W. Glass 4 February 2026 0 0 3,313
Andrew G. Inglis 31 January 2026 0 297,660 0
Andrew G. Inglis 3 February 2026 118,539 0 103,554
Andrew G. Inglis 4 February 2026 0 0 44,628
Neal D. Shah 31 January 2026 0 163,350 0
Neal D. Shah 3 February 2026 65,567 0 54,434
Neal D. Shah 4 February 2026 0 0 24,690
The Notification of Dealing Form for each PDMR, which provides full details of
the transactions outlined above, can be found below.
This notification is made in accordance with Article 19 of the EU Market Abuse
Regulation.
Josh R. Marion
Corporate Secretary
CONTACT:
Investor Relations
Jamie Buckland
+44 203 954 2831
jbuckland@kosmosenergy.com
Media Relations
Thomas Golembeski
+1-214-445-9674
tgolembeski@kosmosenergy.com
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Josh R. Marion
b) Position / status SVP and General Counsel
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 58,080 restricted share units granted under the Plan which are scheduled to
vest with respect to one-third of the total number of shares on January 31 of
each of 2027, 2028 and 2029, subject to the terms of the Plan and the
applicable award agreement issued thereunder.
Shares Granted or Vested
c) Currency USD
Price 1.58
Volume 58,080
Total 91,766.40
Shares sold or withheld
Currency USD
Price 0
Volume 0
Total 0
d) Aggregated information
Price 1.58
Volume 58,080
Total 91,766.40
e) Date of the transactions 31 January 2026
f) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 7,661 shares issued on settlement of restricted share units granted to the
reporting person on 31 January 2023 under the Company's Long Term Incentive
Plan (the "Plan") based on the target level of achievement of the applicable
performance condition.
Shares Granted or Vested
c) Currency USD
Price 1.380
Volume 7,661
Total 10,572.18
Shares sold or withheld
Currency USD
Price 0
Volume 0
Total 0
d) Aggregated information
Price 1.38
Volume 7,661
Total 10,572.18
e) Date of the transactions 3 February 2026
f) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 19,656 shares sold to satisfy the tax withholding requirement arising from the
vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
Currency USD
Price 1.37
Volume 19,656
Total 26,928.72
d) Aggregated information
Price 1.37
Volume 19,656
Total 26,928.72
e) Date of the transactions 3 February 2026
f) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 3,284 shares sold to satisfy the tax withholding requirement arising from the
vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
Currency USD
Price 1.42
Volume 3,284
Total 4,663.28
d) Aggregated information
Price 1.42
Volume 3,284
Total 4,663.28
e) Date of the transactions 4 February 2026
f) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Ronald W. Glass
b) Position / status Vice President and Chief Accounting Officer
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 55,000 restricted share units granted under the Plan which are scheduled to
vest with respect to one-third of the total number of shares on January 31 of
each of 2027, 2028 and 2029, subject to the terms of the Plan and the
applicable award agreement issued thereunder.
Shares Granted or Vested
c) Currency USD
Price 1.58
Volume 55,000
Total 86,900.00
Shares sold or withheld
Currency USD
Price 0
Volume 0
Total 0
d) Aggregated information
Price 1.58
Volume 55,000
Total 86,900.00
e) Date of the transactions 31 January 2026
f) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 7,732 shares issued on settlement of restricted share units granted to the
reporting person on 31 January 2023 under the Company's Long Term Incentive
Plan (the "Plan") based on the target level of achievement of the applicable
performance condition.
Shares Granted or Vested
c) Currency USD
Price 1.38
Volume 7,732
Total 10,670.16
Shares sold or withheld
Currency USD
Price 0
Volume 0
Total 0
d) Aggregated information
Price 1.38
Volume 7,732
Total 10,670.16
e) Date of the transactions 3 February 2026
f) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 19,285 shares sold to satisfy the tax withholding requirement arising from the
vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
Currency USD
Price 1.37
Volume 19,285
Total 26,420.45
d) Aggregated information
Price 1.37
Volume 19,285
Total 26,420.45
e) Date of the transactions 3 February 2026
f) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 3,313 shares sold to satisfy the tax withholding requirement arising from the
vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
Currency USD
Price 1.42
Volume 3,313
Total 4,704.46
d) Aggregated information
Price 1.42
Volume 3,313
Total 4,704.46
e) Date of the transactions 4 February 2026
f) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Andrew G. Inglis
b) Position / status Chairman and Chief Executive Officer
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 297,660 restricted share units granted under the Plan which are scheduled to
vest with respect to one-third of the total number of shares on January 31 of
each of 2027, 2028 and 2029, subject to the terms of the Plan and the
applicable award agreement issued thereunder.
Shares Granted or Vested
c) Currency USD
Price 1.58
Volume 297,660
Total 470,302.80
Shares sold or withheld
Currency USD
Price 0
Volume 0
Total 0
d) Aggregated information
Price 1.58
Volume 297,660
Total 470,302.80
e) Date of the transactions 31 January 2026
f) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 118,539 shares issued on settlement of restricted share units granted to the
reporting person on 31 January 2023 under the Company's Long Term Incentive
Plan (the "Plan") based on the target level of achievement of the applicable
performance condition.
Shares Granted or Vested
c) Currency USD
Price 1.38
Volume 118,539
Total 163,583.82
Shares sold or withheld
Currency USD
Price 0
Volume 0
Total 0
d) Aggregated information
Price 1.38
Volume 118,539
Total 163,583.82
e) Date of the transactions 3 February 2026
f) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 103,554 shares sold to satisfy the tax withholding requirement arising from
the vesting of restricted shares granted to the reporting person under the
Plan.
Shares Granted or Vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
Currency USD
Price 1.37
Volume 103,554
Total 141,868.98
d) Aggregated information
Price 1.37
Volume 103,554
Total 141,868.98
e) Date of the transactions 3 February 2026
f) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 44,628 shares sold to satisfy the tax withholding requirement arising from the
vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
Currency USD
Price 1.42
Volume 44,628
Total 63,371.76
d) Aggregated information
Price 1.42
Volume 44,628
Total 63,371.76
e) Date of the transactions 4 February 2026
f) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Neal D. Shah
b) Position / status Senior Vice President and Chief Financial Officer
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 163,350 restricted share units granted under the Plan which are scheduled to
vest with respect to one-third of the total number of shares on January 31 of
each of 2027, 2028 and 2029, subject to the terms of the Plan and the
applicable award agreement issued thereunder.
Shares Granted or Vested
c) Currency USD
Price 1.58
Volume 163,350
Total 258,093
Shares sold or withheld
Currency USD
Price 0
Volume 0
Total 0
d) Aggregated information
Price 1.58
Volume 163,350
Total 258,093
e) Date of the transactions 31 January 2026
f) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 65,567 shares issued on settlement of restricted share units granted to the
reporting person on 31 January 2023 under the Company's Long Term Incentive
Plan (the "Plan") based on the target level of achievement of the applicable
performance condition.
Shares Granted or Vested
c) Currency USD
Price 1.38
Volume 65,567
Total 90,482.46
Shares sold or withheld
Currency USD
Price 0
Volume 0
Total 0
d) Aggregated information
Price 1.38
Volume 65,567
Total 90,482.46
e) Date of the transactions 3 February 2026
f) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 54,434 shares sold to satisfy the tax withholding requirement arising from the
vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
Currency USD
Price 1.37
Volume 54,434
Total 74,574.58
d) Aggregated information
Price 1.37
Volume 54,434
Total 74,574.58
e) Date of the transactions 3 February 2026
f) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Stock, par value $0.01 per share
b) Nature of the transactions 24,690 shares sold to satisfy the tax withholding requirement arising from the
vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
Currency USD
Price 1.42
Volume 24,690
Total 35,059.80
d) Aggregated information
Price 1.42
Volume 24,690
Total 35,059.80
e) Date of the transactions 4 February 2026
f) Place of the transaction NYSE
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHSSLSSMEMSESE
Copyright 2019 Regulatory News Service, all rights reserved